...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >The role of p53 in the cellular toxicity by active trans-platinum complexes containing isopropylamine and hydroxymethylpyridine.
【24h】

The role of p53 in the cellular toxicity by active trans-platinum complexes containing isopropylamine and hydroxymethylpyridine.

机译:p53在含有异丙胺和羟甲基吡啶的活性反式铂络合物的细胞毒性中的作用。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Despite some initial research that reported a lack of activity of trans geometry, complexes with general formula trans-[PtCl2(L)(L')] exhibit an important cytotoxic activity in cisplatin-sensitive and resistant cell lines. Based on the proposed mechanism of action for the trans-platinum compounds, they might form DNA adducts initiating a DNA-damage response and ultimately ending in the activation of the p53 protein. In the present work, we have studied the biochemical properties of the trans-[PtCl2(isopropylamine)(L)] complexes (where L is 3- or 4-(hydroxymethyl)-pyridine) against several cell lines and the relationship between cytotoxicity and the protein p53. Both complexes showed different antitumoral properties depending on the presence or absence of protein p53 in isogenic colon carcinoma HCT116 cell lines. Cell cycle studies with the complexes in these cell lines were performed to investigate their antitumoral activity. Apoptosis was observed to be launched from G1 or G2/M accumulations. Confocal microscopy showed the different behaviour of isogenic tumoral cell lines treated with the trans-platinum complexes. Our data suggest that small differences in the carrier ligands could play an important role in the overall biological effects. The body of the research regarding structure-activity relationships such as the different position of groups in the carrier ligands will provide new rational basis for the design of new platinum antitumor drugs.
机译:尽管有一些初步的研究报道缺乏反式几何活性,但具有通式反式-[PtCl2(L)(L')]的复合物在顺铂敏感性和耐药性细胞系中显示出重要的细胞毒性活性。基于所提出的反铂化合物的作用机理,它们可能形成DNA加合物,引发DNA损伤反应并最终终止p53蛋白的活化。在目前的工作中,我们研究了反式-[PtCl2(异丙胺)(L)]配合物(其中L为3-或4-(羟甲基)-吡啶)对几种细胞系的生化特性以及细胞毒性与蛋白p53。两种复合物均显示出不同的抗肿瘤特性,这取决于同基因结肠癌HCT116细胞系中是否存在蛋白p53。用这些细胞系中的复合物进行细胞周期研究以研究其抗肿瘤活性。观察到细胞凋亡是从G1或G2 / M积累开始的。共聚焦显微镜显示了用反铂复合物处理的同基因肿瘤细胞系的不同行为。我们的数据表明载体配体中的细微差异可能在整体生物学效应中起重要作用。有关结构-活性关系(如基团在载体配体中的位置不同)的研究机构,将为设计新的铂类抗肿瘤药物提供新的合理依据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号